
Neladalkib received accelerated approval for adults with advanced ALK-positive NSCLC after specified prior therapies, supported by durable responses in the ALKOVE-1 trial.
The National Community Pharmacists Association is pleased to announce these upcoming events for pharmacists and pharmacy team members:
REMINDER: Members of the media interested in attending NCPA’s Annual Convention should contact Andie Pivarunas to register.
Events are subject to change. Visit our website for the latest information on NCPA events.






